Cysteinyl leukotriene receptor antagonists inhibit tumor metastasis by inhibiting capillary permeability

Keio Journal of Medicine

Volumn 59, Issue 1, 2010, Pages 10-18

  Nozaki, Masako ^a,b,c   Yoshikawa, Masanobu ^a   Ishitani, Kunihiko ^b   Kobayashi, Hiroyuki ^a,c   Houkin, Kiyohiro ^d   Imai, Kohzoh ^d   Ito, Yoichiro ^c,e   Muraki, Takamura ^c,f  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Higashi Sapporo Hospital   (Japan)

^c Inflammation Research Center Co Ltd   (Japan)

^d SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Capillary permeability; Cysteinyl leukotriene receptor antagonist; Metastasis inhibition; Montelukast; Pranlukast

Indexed keywords

LEUKOTRIENE RECEPTOR; MONTELUKAST; PRANLUKAST;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CANCER MODEL; CAPILLARY PERMEABILITY; CELL MIGRATION; COLON CANCER; EXTRAVASATION; LEUKOCYTE; LEWIS CARCINOMA; LUNG METASTASIS; NONHUMAN; SURVIVAL RATE; TUMOR CELL;

ACETATES; ANIMALS; CAPILLARY PERMEABILITY; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CHROMONES; COLONIC NEOPLASMS; FEMALE; LEUKOTRIENE ANTAGONISTS; MALE; MICE; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; QUINOLINES; RATS; RATS, INBRED F344;

EID: 77954258075     PISSN: 00229717     EISSN: 18801293     Source Type: Journal    
DOI: 10.2302/kjm.59.10     Document Type: Article

References (20)

1. Hoff SD, Matsushita Y, Ota DM, Cleary KR, Yamori T, Hakomori S, Irimura T: Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma. Cancer Res 1989; 49: 6883-6888.
2. Hoff SD, Irimura T, Matsushita Y, Ota DM, Cleary KR, Hakomori S: Metastatic potential of colon carcinoma: Expression of ABO/Lewis-related antigens. Arch Surg 1990; 125: 206-209.
3. Kannagi R: Roles of cell adhesion molecules in cancer metastasis. Nippon Rinsho 2003; 61 suppl 8: 87-93.
4. Kaplan E MP: Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457-481.
5. Wilkinson R: Pharmakokinetics: The dynamics of drug absorption, distribution, and elimination. In Hardman GJ, Limbird EL, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics 10th Ed, New York NY: McGraw-Hill, 2001; 3-29.
6. Ishido M, Shibakawa K, Nakao Y, Sawada M, Aishita H: Studies on the metabolic fate of leukotriene antagonist ONO-1078 (1): Absorption, distribution and excretion after single administration to rats. Yakubutsudoutai 1993; 8: 3-26.
7. Kanazawa H, Yoshikawa T, Hirata K, Yoshikawa J: Effects of pranlukast administration on vascular endothelial growth factor levels in asthmatic patients. Chest 2004; 125: 1700-1705.
8. Lee KS, Kim SR, Park HS, Jin GY, Lee YC: Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression. J Allergy Clin Immunol 2004; 114: 1093-1099.
9. Ishido M, Shibakawa K, Takamoto M, Kajiwara I, Sawada M, Aishita H: Studies on the metabolic fate of leukotriene antagonist ONO-1078 (4); Metabolism and protein binding. Yakubutsudoutai 1993; 8: 49-66.
10. Bochnowicz S, Underwood DC: Dose-dependent mediation of leukotriene D4-induced airway microvascular leakage and bronchoconstriction in the guinea pig. Prostaglandins Leukot Essent Fatty Acids 1995; 52: 403-411.
11. Wenzel SE: Arachidonic acid metabolites: mediators of inflammation in asthma. Pharmacotherapy 1997; 17: 3S-12S.
12. Tan RA, Spector SL: Antileukotriene agents. Curr Opin Pulm Med 1997; 3: 215-220.
13. Liu YC, Khawaja AM, Rogers DF: Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin-sensitized guinea-pigs in vitro. Br J Pharmacol 1998; 124: 563-571.
14. Bisgaard H: Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma. Allergy 2001; 56 Suppl 66: 7-11.
15. Hele DJ, Birrell MA, Webber SE, Foster ML, Belvisi MG: Mediator involvement in antigen-induced bronchospasm and microvas Nozaki M, et al: Pranlukast Inhibits Tumor Metastasis cular leakage in the airways of ovalbumin sensitized Brown Norway rats. Br J Pharmacol 2001; 132: 481-488.
16. Peters-Golden M, Henderson WR Jr: The role of leukotrienes in allergic rhinitis. Ann Allergy Asthma Immunol 2005; 94: 609-618.
17. Kobayashi K, Matsumoto S, Morishima T, Kawabe T, Okamoto T: Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer Res 2000; 60: 3978-3984.
18. Armitage OJ, Sidner DR: Antitumor effect of cimetidine? The Lancet 1979; 313: 882-883.
19. Matsumoto S, Imaeda Y, Umemoto S, Kobayashi K, Suzuki H, Okamoto T: Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis -A epitope expression on tumor cells. Brit J Can 2002; 86: 161-167.
20. Obase Y, Shimoda T, Matsuse H, et al: The position of pranlukast, a cysteinyl leukotriene receptor antagonist, in the long term treatment of asthma. 5-year follow-up study. Respiration 2004; 71: 225-232.